C127I Cells
CAD$545.10*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | The C127I cell line is a murine mammary gland epithelial cell line, commonly used in biomedical research for its ability to synthesize and secrete recombinant proteins. These cells originate from the mammary gland of the BALB/c mouse and are particularly noted for their epithelial morphology and responsiveness to hormones and other growth factors. The C127I cell line has been instrumental in the study of gene expression, signal transduction pathways related to cancer development, and the production of viral vectors for gene therapy. One of the key features of the C127I cell line is its ability to be easily transfected, making it a valuable tool for the production of recombinant proteins and for gene editing studies. It supports the replication of various murine retroviruses, facilitating the production of stable recombinant lines expressing desirable genes. This characteristic has made C127I cells especially useful in the fields of molecular biology and genetics, where they are often employed to explore the effects of gene overexpression or knockdown in a controlled environment. |
|---|---|
| Organism | Mouse |
| Tissue | Breast, mammary gland |
| Disease | Carcinoma |
| Applications | Transfection host for transformation with bovine papilloma virus DNA plasmids. Visualization of sarcoma virus-induced foci. Quantitative in vitro assays for bovine papilloma virus. |
| Synonyms | C 1271, C-127I, C-127 I, CNC 127I |
Characteristics
| Breed/Subspecies | RIII |
|---|---|
| Gender | Female |
| Morphology | Epithelial-like |
| Growth properties | Adherent |
Regulatory Data
| Citation | C127I (Cytion catalog number 400134) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 10090 |
| CellosaurusAccession | CVCL_3882 |
| GMO Status | GMO-S1: This murine breast carcinoma cell line (C127I) contains recombinant viral sequences encoding T7 RNA polymerase and CFTR delivered via infection with engineered viruses, functioning as a transfection host. The construct is stably integrated into C127 cells. This classification applies only within Germany and may differ elsewhere. |
Biomolecular Data
| Viruses | Negative for ectromelia virus (mousepox). |
|---|---|
| Virus susceptibility | Bovine papilloma virus |
| Reverse transcriptase | Negative (as determined in supernatant fluid) |
Handling
| Culture Medium | DMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 3.7 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a) |
|---|---|
| Supplements | Supplement the medium with 10% FBS |
| Dissociation Reagent | Accutase |
| Subculturing | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| Fluid renewal | 2 to 3 times per week |
| Post-Thaw Recovery | After thawing, plate the cells at 5 x 104 cells/cm2 and allow the cells to recover from the freezing process and to adhere for at least 24 hours. |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 400134-060825 | Certificate of Analysis | 22. Oct. 2025 | 400134 |
| 400134-412 | Certificate of Analysis | 23. May. 2025 | 400134 |